KESTRA MEDICAL TECHNOLOGIES, LTD. 8-K

What Happened
Kestra Medical Technologies, Ltd. announced and furnished a press release dated March 17, 2026 reporting its financial results for the fiscal quarter ended January 31, 2026. The company filed an 8-K (Item 2.02) on March 17, 2026 to disclose those quarterly results; the release is included as Exhibit 99.1.

Key Details

• Press release announcing quarterly financial results dated March 17, 2026 was furnished as Exhibit 99.1 to the 8-K.
• The filing covers results for the fiscal quarter ended January 31, 2026 (no specific revenue or earnings figures were included in the 8-K text).
• The Form 8-K was signed by Brian Webster, President and Chief Executive Officer, on March 17, 2026.
• The filing also includes the Inline XBRL cover page (Exhibit 104).

Why It Matters
This filing formally notifies investors that Kestra has reported its most recent quarterly financial performance and made the details available via a press release. Investors should review the furnished press release and any accompanying financial statements or XBRL data (Exhibit 99.1 / 104) to see revenue, earnings, and other metrics; the 8-K itself does not include the numeric results. Tracking these quarterly results helps investors assess recent business performance and compare trends quarter-to-quarter.